Browsing byAuthorYoon S.-S.

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 25 of 25

Issue DateTitleAuthor(s)Type
2006A multicenter retrospective analysis of adverse events in Korean patients using bortezomib for multiple myeloma성주명Article
2017A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalanprednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma문영철Article
2014Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: A prospective multicenter study문영철Article
2014Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: Web-based multicenter registry study문영철Article
2009Clinical features and survival outcomes in patients with multiple myeloma: Analysis of web-based data from the korean myeloma registry문영철Article
2021Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone문영철Article
2013Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes성주명; 문영철Article
2010Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine문영철Article
2015Cytidine deaminase polymorphisms and worse treatment response in normal karyotype AML김형래Article
2014Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia성주명Article
2013Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation문영철Article
2006Effects of pure curry consumption on life span, body weight, and weight of organs in mice transplanted with cancer cells정명수Article
2013Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia문영철Article
2005High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization성주명Article
2018Identification of Novel Functional Variants of SIN3A and SRSF1 among Somatic Variants in Acute Myeloid Leukemia Patients김형래Article
2017Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia김형래Article
2001Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study이순남Article
2014Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea - Experience from 110 patients문영철Article
2010Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide문영철Article
2013Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT문영철Article
2003Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: Multicenter trial성주명Article
2018Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)문영철Article
2020Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples김형래Article
2012Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: Results of a phase II trial성주명Article
2017The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: A retrospective multicenter study (KMM160)문영철Article

BROWSE